Brian Windsor
Chief Executive Officer chez AILERON THERAPEUTICS, INC.
Fortune : 48 711 $ au 31/03/2024
Profil
Brian J.
Windsor was the founder of Texagen, Inc. (founded in 1999) where he held the title of Vice President-Research & Development from 1999 to 2003.
He is currently the President, Chief Executive Officer & Director at Aileron Therapeutics, Inc. since 2024.
In his former positions, he served as the President, Chief Executive Officer & Director at Lung Therapeutics LLC, Director & Chief Scientific Officer at TFF Pharmaceuticals, Inc. from 2018 to 2022, and Senior Vice President-Portfolio Company Management at Emergent Technologies, Inc. from 2010 to 2013.
He also held positions as President at Reveal Sciences LLC, Mimetic Solutions LLC, and Coradyn Biosystems LLC, as well as Chief Technology Officer at Auxano Biomedical LLC.
From 2009 to 2013, he was the President of Enavail LLC and President of Appian Labs LLC.
Dr. Windsor obtained his undergraduate degree from The University of Texas at Austin and his doctorate degree in 2000 from the same institution.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/03/2024 | 7 347 ( 0,15% ) | 48 711 $ | 31/03/2024 |
Postes actifs de Brian Windsor
| Sociétés | Poste | Début |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Executive Officer | 11/03/2024 |
Anciens postes connus de Brian Windsor
| Sociétés | Poste | Fin |
|---|---|---|
| TFF PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 21/03/2022 |
Emergent Technologies, Inc.
 Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Corporate Officer/Principal | 01/03/2013 |
Enavail LLC
 Enavail LLC Pharmaceuticals: OtherHealth Technology Enavail LLC produces bioactive peptides and compounds for clinical research. Its technology focuses on generating crystalline or amorphous forms of poorly water-soluble compounds, providing enhanced dissolution and bioavailability, and producing powder forms of labile proteins. The company was founded in 2009 and is headquartered in Austin, TX. | President | 01/03/2013 |
| Texagen, Inc. | Founder | 01/07/2003 |
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Chief Executive Officer | - |
Formation de Brian Windsor
| The University of Texas at Austin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| TFF PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Health Technology |
Emergent Technologies, Inc.
Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Finance |
Reveal Sciences LLC
 Reveal Sciences LLC Specialty StoresRetail Trade Reveal Sciences LLC provides personal care products. It offers real-time visual product feedback through color changing technology and caretype analysis for skin and hair conditions as well as specialty biomaterials to meet product formulation needs. The company was founded on November 12, 2007 and is headquartered in Austin, TX | Retail Trade |
Mimetic Solutions LLC
 Mimetic Solutions LLC Pharmaceuticals: MajorHealth Technology Mimetic Solutions LLC develops and distributes drugs and chemicals. Its product brands include TheraSmart and BeautySmart. The company was founded by Nicholas A. Peppas and Zach J. Hilt in 2006 and is headquartered in Austin, TX. | Health Technology |
Auxano Biomedical LLC
 Auxano Biomedical LLC Medical SpecialtiesHealth Technology Auxano Biomedical LLC designed and distributed medical devices. The company was founded by Ted W. Reid in and was headquartered in Austin, TX. | Health Technology |
Coradyn Biosystems LLC
 Coradyn Biosystems LLC SemiconductorsElectronic Technology Coradyn Biosystems LLC developed technology for sensor applications. It offered wireless enabled sensors for clinical devices. The company was headquartered in Austin, TX. | Electronic Technology |
| Texagen, Inc. | |
Enavail LLC
Enavail LLC Pharmaceuticals: OtherHealth Technology Enavail LLC produces bioactive peptides and compounds for clinical research. Its technology focuses on generating crystalline or amorphous forms of poorly water-soluble compounds, providing enhanced dissolution and bioavailability, and producing powder forms of labile proteins. The company was founded in 2009 and is headquartered in Austin, TX. | Health Technology |
Appian Labs LLC
 Appian Labs LLC Pharmaceuticals: MajorHealth Technology Appian Labs LLC is a biopharmaceutical company, which provides therapeutic design and delivery services. The firm engages in drug formulation services to pharmaceutical companies. The company was founded by Peppas A. Nicholas in March 2007 and is headquartered in Austin, TX. | Health Technology |
